U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H13BrN2O6
Molecular Weight 349.135
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SORIVUDINE

SMILES

OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O

InChI

InChIKey=GCQYYIHYQMVWLT-HQNLTJAPSA-N
InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula C11H13BrN2O6
Molecular Weight 349.135
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 1
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/1653394 http://www.chemdrug.com/article/8/3284/16419323.html

SORIVUDINE (BV-araU) is an Anti-Herpes Virus Drugs, which was Withdrawn in 1995. Aantiviral action of BV-araU against VZV (varicella-zoster virus) and herpes simplex virus type 1 (HSV-1) is based on the inhibition of DNA synthesis in herpesvirus-infected cells.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: synthesis of virus DNA
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
1981 Jul
Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
1981 Nov
Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
1981 Sep
Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.
1988 Jul
Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
1988 Jul
Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
1988 Oct
(E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
1989 Jun 15
Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed mice.
1990 Dec
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.
1990 Dec
Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
1990 Jul
Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulence.
1990 May
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.
1992 May 15
Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
1996 Apr
Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
1997 Aug
A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities.
1997 Jul 4
Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus.
1998 Aug
Selective activity of various antiviral compounds against HHV-7 infection.
1999 Aug
Synthesis of novel 4'-C-methyl-pyrimidine nucleosides and their biological activities.
1999 Mar 22
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.
2001 May 21
In vitro activity of potential anti-poxvirus agents.
2003 Jan
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
2004 Mar
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
2004 Mar 19
Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines.
2004 Oct 15
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
2005 Mar
Patents

Sample Use Guides

In Vivo Use Guide
for mice: 5% BV-araU (SORIVUDINE) cream given 4 times daily for 5 days starting 1 day after inoculation
Route of Administration: Topical
In Vitro Use Guide
The inhibitory effect of BV-araU (SORIVUDINE) on DNA synthesis in human embryonic lung cells infected with varicella-zoster virus (VZV) or herpes simplex virus type 1 (HSV-1) was compared with that of acyclovir. he inhibitory concentration of BV-araU for DNA synthesis in VZV-infected cells was one-thousandth of that of acyclovir.
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:57:30 GMT 2023
Edited
by admin
on Sat Dec 16 15:57:30 GMT 2023
Record UNII
C7VOZ162LV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SORIVUDINE
INN   JAN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
SORIVUDINE [MART.]
Common Name English
SQ 32,756
Code English
SO-32756
Code English
SORIVUDINE [JAN]
Common Name English
SQ-32756
Code English
SORIVUDINE [MI]
Common Name English
Sorivudine [WHO-DD]
Common Name English
sorivudine [INN]
Common Name English
BRAVAVIR
Brand Name English
YN-72
Code English
SORIVUDINE [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 92295
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
NCI_THESAURUS C281
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
NCI_THESAURUS C2019
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
Code System Code Type Description
DRUG BANK
DB11998
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
EPA CompTox
DTXSID6057827
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
FDA UNII
C7VOZ162LV
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
WIKIPEDIA
SORIVUDINE
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL70046
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
CAS
77181-69-2
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
EVMPD
SUB10605MIG
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
SMS_ID
100000083796
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
INN
6695
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
USAN
EE-52
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
DRUG CENTRAL
2463
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
PUBCHEM
5282192
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
MERCK INDEX
m10123
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY Merck Index
MESH
C031368
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
NCI_THESAURUS
C1460
Created by admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY